{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:50:13Z","timestamp":1788587413718,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029162\/1"],"award-info":[{"award-number":["MR\/W029162\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022244","name":"National Institute for Health Research Applied Research Collaboration West","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022244","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR HPRU BSE"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Co-use of benzodiazepines and\/or \u2018z-drugs\u2019 along with opioids is linked to the rise in drug related deaths (DRD) in the UK. Understanding patterns of co-use could inform harm reduction strategies for reducing DRDs. This study explored how people co-use, including dosages, timings, methods of administration, use of other substances and desired effects sought.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty-eight semi-structured interviews across Glasgow in Scotland (n\u2009=\u200928), Bristol (n\u2009=\u200910) and Teesside (n\u2009=\u200910) in England with individuals who co-use illicit and\/or prescribed opioids and benzodiazepines\/z-drugs were conducted. Eighteen interviews were co-facilitated with qualitatively trained local peer researchers. Interviews were analysed using the Framework method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six co-use patterns were generated: (1) co-use to aid sleep or come down, (2) curated co-use, opioid agonist therapy (OAT) only (3) morning and evening benzodiazepine doses with opioids throughout the day (4) co-use binges (5) co-use throughout the day, (6) benzodiazepine use throughout the day plus OAT. Patterns one to three reflected more controlled co-use with a focus on self-medicating to give confidence, manage anxiety, promote sleep and come-down from cocaine\/ketamine. Patterns four to six involved greater poly-drug use, and less controlled co-use with a focus on seeking euphoria (\u201cwarm glow\u201d, \u201cgouching out\u201d) or oblivion (to escape untreated mental health conditions and trauma). Patterns two, three, five and six involved daily co-use. People switched between patterns depending on available resources (e.g. finances) or changes to prescriptions (opioids or benzodiazepines). Near-fatal overdoses were reported by participants across all co-use patterns. Patterns four to six were conceptualised as presenting greater overdose risk due to less controlled co-use and more extensive polydrug use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The patterns identified provide opportunities for future harm reduction strategies, tailoring advice to patterns of use, updated prescribing guidance and policies, and the need for better access to mental health care, for people who co-use benzodiazepines and opioids to reduce DRDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01153-8","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:45:08Z","timestamp":1740728708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A qualitative study of benzodiazepine\/z-drug and opioid co-use patterns and overdose risk"],"prefix":"10.1186","volume":"22","author":[{"given":"Hannah E.","family":"Family","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Vojt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Abdala Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiana","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Kesten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"8","key":"1153_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S2215-0366(19)30209-3","volume":"6","author":"J Kimber","year":"2019","unstructured":"Kimber J, Hickman M, Strang J, Thomas K, Hutchinson S. Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis. Lanc Psychiatr. 2019;6(8):639\u201340.","journal-title":"Lanc Psychiatr"},{"key":"1153_CR2","unstructured":"Gov.UK. From Harm to Hope; a 10-year drugs plan to cut crime and save lives."},{"key":"1153_CR3","unstructured":"Office for National Statistics (ONS). Deaths related to drug poisoning in England and Wales QMI. 2020."},{"key":"1153_CR4","doi-asserted-by":"publisher","first-page":"103512","DOI":"10.1016\/j.drugpo.2021.103512","volume":"100","author":"A McAuley","year":"2022","unstructured":"McAuley A, Matheson C, Robertson JR. From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic. Int J Drug Policy. 2022;100:103512.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"1153_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000516165","volume":"27","author":"J van Amsterdam","year":"2021","unstructured":"van Amsterdam J, van den Brink W, Pierce M. Explaining the differences in opioid overdose deaths between Scotland and england\/wales: implications for European Opioid policies. Eur Addict Res. 2021;27(6):399\u2013412.","journal-title":"Eur Addict Res"},{"key":"1153_CR6","unstructured":"UK Health Security Agengcy. Office for health improvement and disparities. Estimates of opiate and crack use in England: main points and methods. 2023."},{"key":"1153_CR7","unstructured":"Office for Health Improvement and disparities. Adult substance misuse treatment statistics 2023\u20132024: report. London; 2024."},{"key":"1153_CR8","unstructured":"Public Health Scotland. Estimated prevalence of Opioid dependence in Scotland 2014\/15 to 2019\/20. 2024."},{"issue":"8","key":"1153_CR9","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/add.16500","volume":"119","author":"A Markoulidakis","year":"2024","unstructured":"Markoulidakis A, Hickman M, McAuley A, Barnsdale LR, Welton NJ, Glancy M, et al. Prevalence of opioid dependence in Scotland 2015\u20132020: a multi-parameter estimation of prevalence (MPEP) study. Addiction. 2024;119(8):1410\u201320.","journal-title":"Addiction"},{"key":"1153_CR10","unstructured":"Public Health Scotland. Estimated quarterly numbers of people prescribed opioid substitution therapy in Scotland (12-month period). 2024."},{"key":"1153_CR11","unstructured":"Office for National Statistics (ONS). Deaths related to drug poisoning in England and Wales: 2023 registrations. 2024."},{"key":"1153_CR12","unstructured":"Burns D. Drug-related deaths in Scotland in 2022. Edinburgh: national records of Scotland; 2023."},{"key":"1153_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drugpo.2017.05.016","volume":"46","author":"P Mateu-Gelabert","year":"2017","unstructured":"Mateu-Gelabert P, Jessell L, Goodbody E, Kim D, Gile K, Teubl J, et al. High enhancer, downer, withdrawal helper: multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City. Int J Drug Policy. 2017;46:17\u201327.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1153_CR14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/bcp.14397","volume":"87","author":"J Hockenhull","year":"2021","unstructured":"Hockenhull J, Black JC, Haynes CM, Rockhill K, Dargan PI, Dart RC, et al. Nonmedical use of benzodiazepines and Z-drugs in the UK. Br J Clin Pharmacol. 2021;87(4):1676\u201383.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1153_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1360-0443.2006.01688.x","volume":"102","author":"M Hickman","year":"2007","unstructured":"Hickman M, Carrivick S, Paterson S, Hunt N, Zador D, Cusick L, et al. London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring. Addiction. 2007;102(2):317\u201323.","journal-title":"Addiction"},{"issue":"7","key":"1153_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1176\/appi.ajp.2020.20081174","volume":"178","author":"KY Xu","year":"2021","unstructured":"Xu KY, Borodovsky JT, Presnall N, Mintz CM, Hartz SM, Bierut LJ, et al. Association between benzodiazepine or Z-drug prescriptions and drug-related poisonings among patients receiving buprenorphine maintenance: a case-crossover analysis. Am J Psychiatry. 2021;178(7):651\u20139.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"1153_CR17","doi-asserted-by":"publisher","first-page":"e1002965","DOI":"10.1371\/journal.pmed.1002965","volume":"16","author":"J Macleod","year":"2019","unstructured":"Macleod J, Steer C, Tilling K, Cornish R, Marsden J, Millar T, et al. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK clinical practice research datalink and office for national statistics death records. PLoS Med. 2019;16(11):e1002965.","journal-title":"PLoS Med"},{"key":"1153_CR18","doi-asserted-by":"crossref","unstructured":"Tardelli VS, Bianco MCM, Prakash R, Segura LE, Castaldelli-Maia JM, Fidalgo TM, et al. Overdose deaths involving non-BZD hypnotic\/sedatives in the USA: trends analyses. The lancet regional health \u2013 Americas. 2022;10.","DOI":"10.1016\/j.lana.2022.100190"},{"issue":"1","key":"1153_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","volume":"87","author":"J Bell","year":"2020","unstructured":"Bell J, Strang J. Medication treatment of opioid use disorder. Biol Psychiat. 2020;87(1):82\u20138.","journal-title":"Biol Psychiat"},{"key":"1153_CR20","doi-asserted-by":"crossref","unstructured":"Domzaridou E, Carr MJ, Webb RT, Millar T, Ashcroft DM. Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records. The Lancet Regional Health \u2013 Europe. 2022;22.","DOI":"10.1016\/j.lanepe.2022.100489"},{"key":"1153_CR21","unstructured":"Joint Formulary Committee. British National Formulary (online): Hypnotics and anxiolytics London: BMJ and Pharmaceutical Press; [Available from: https:\/\/bnf.nice.org.uk\/treatment-summaries\/hypnotics-and-anxiolytics\/."},{"key":"1153_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","volume":"68","author":"MD Stein","year":"2016","unstructured":"Stein MD, Kanabar M, Anderson BJ, Lembke A, Bailey GL. Reasons for benzodiazepine use among persons seeking opioid detoxification. J Subst Abuse Treat. 2016;68:57\u201361.","journal-title":"J Subst Abuse Treat"},{"key":"1153_CR23","doi-asserted-by":"publisher","first-page":"102823","DOI":"10.1016\/j.drugpo.2020.102823","volume":"82","author":"T May","year":"2020","unstructured":"May T, Holloway K, Buhociu M, Hills R. Not what the doctor ordered: motivations for nonmedical prescription drug use among people who use illegal drugs. Int J Drug Policy. 2020;82:102823.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1153_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0376-8716(81)90061-2","volume":"8","author":"ML Stitzer","year":"1981","unstructured":"Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthorne JW. Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend. 1981;8(3):189\u201399.","journal-title":"Drug Alcohol Depend"},{"key":"1153_CR25","doi-asserted-by":"crossref","unstructured":"Blanco C, Han B, Jones CM, Johnson K, Compton WM. Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States. J Clin Psychiatry. 2018;79(6).","DOI":"10.4088\/JCP.18m12174"},{"issue":"1\u20132","key":"1153_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1\u20132):8\u201318.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1153_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","volume":"25","author":"B M\u00e9garbane","year":"2006","unstructured":"M\u00e9garbane B, Hreiche R, Pirnay S, Marie N, Baud FJ. Does high-dose buprenorphine cause respiratory depression?: Possible mechanisms and therapeutic consequences. Toxicol Rev. 2006;25(2):79\u201385.","journal-title":"Toxicol Rev"},{"key":"1153_CR28","doi-asserted-by":"publisher","first-page":"104025","DOI":"10.1016\/j.drugpo.2023.104025","volume":"116","author":"HL Poulter","year":"2023","unstructured":"Poulter HL, Walker T, Ahmed D, Moore HJ, Riley F, Towl G, et al. More than just \u2018free heroin\u2019: caring whilst navigating constraint in the delivery of diamorphine assisted treatment. Int J Drug Policy. 2023;116:104025.","journal-title":"Int J Drug Policy"},{"issue":"13","key":"1153_CR29","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753\u201360.","journal-title":"Qual Health Res"},{"key":"1153_CR30","doi-asserted-by":"crossref","unstructured":"Horwood J, Pithara C, Lorenc A, Kesten JM, Murphy M, Turner A, et al. The experience of conducting collaborative and intensive pragmatic qualitative (CLIP-Q) research to support rapid public health and healthcare innovation. Frontiers in Sociology. 2022;7.","DOI":"10.3389\/fsoc.2022.970333"},{"issue":"7","key":"1153_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1037\/0003-066X.32.7.513","volume":"32","author":"U Bronfenbrenner","year":"1977","unstructured":"Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977;32(7):513.","journal-title":"Am Psychol"},{"key":"1153_CR33","doi-asserted-by":"crossref","unstructured":"Vojt G, Family H, Poulter H, Bailey C, Cavallo D, Abdala Sheikh A, et al. Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study. medRxiv. 2024:2024.11.29.24318190.","DOI":"10.1101\/2024.11.29.24318190"},{"key":"1153_CR34","unstructured":"Roche B, Guta A, Flicker S. Peer research in action I: models of practice. Toronto, (ON); 2010."},{"issue":"3","key":"1153_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1521\/aeap.2010.22.3.173","volume":"22","author":"SD Rhodes","year":"2010","unstructured":"Rhodes SD, Malow RM, Jolly C. Community-based participatory research: a new and not-so-new approach to HIV\/AIDS prevention, care, and treatment. AIDS Educ Prev. 2010;22(3):173\u201383.","journal-title":"AIDS Educ Prev"},{"issue":"9","key":"1153_CR36","doi-asserted-by":"publisher","first-page":"e029538","DOI":"10.1136\/bmjopen-2019-029538","volume":"9","author":"M Hickman","year":"2019","unstructured":"Hickman M, John FD, Lawrie E, De Daniela A, Peter V, Graham F, et al. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) \u2013 a natural experiment (protocol). BMJ Open. 2019;9(9):e029538.","journal-title":"BMJ Open"},{"key":"1153_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4135\/9781412986274.n12","volume-title":"The qualitative researcher's companion","author":"J Ritchie","year":"2002","unstructured":"Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Huberman M, Miles M, editors. The qualitative researcher\u2019s companion. London: Sage; 2002. p. 305\u201329."},{"issue":"1","key":"1153_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/nur.20362","volume":"33","author":"M Sandelowski","year":"2010","unstructured":"Sandelowski M. What\u2019s in a name? Qualitative description revisited. Res Nurs Health. 2010;33(1):77\u201384.","journal-title":"Res Nurs Health"},{"issue":"4","key":"1153_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G","volume":"23","author":"M Sandelowski","year":"2000","unstructured":"Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334\u201340.","journal-title":"Res Nurs Health"},{"key":"1153_CR40","unstructured":"Poulter H, Vojt G, Family H, Bailey C, Cavallo D, Abdala Sheikh A, et al. harm reduction strategies used by people who co-use benzodiazepines \/ z-drugs and opioids in the UK: a qualitative study. in preparation."},{"issue":"2","key":"1153_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/add.12408","volume":"109","author":"J Neale","year":"2014","unstructured":"Neale J, Miller P, West R. Reporting quantitative information in qualitative research: guidance for authors and reviewers. Addiction. 2014;109(2):175\u20136.","journal-title":"Addiction"},{"key":"1153_CR42","doi-asserted-by":"publisher","first-page":"111891","DOI":"10.1016\/j.forsciint.2023.111891","volume":"354","author":"LJ Hikin","year":"2024","unstructured":"Hikin LJ, Coombes G, Rice-Davies K, Couchman L, Smith PR, Morley SR. Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales. Forensic Sci Int. 2024;354:111891.","journal-title":"Forensic Sci Int"},{"issue":"3","key":"1153_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/09595239600185971","volume":"15","author":"J Ross","year":"1996","unstructured":"Ross J, Darke S, Hall W. Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procurement. Drug Alcohol Rev. 1996;15(3):237\u201343.","journal-title":"Drug Alcohol Rev"},{"key":"1153_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.drugalcdep.2016.07.003","volume":"166","author":"A Peacock","year":"2016","unstructured":"Peacock A, Bruno R, Larance B, Lintzeris N, Nielsen S, Ali R, et al. Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: a retrospective 7-day diary study. Drug Alcohol Depend. 2016;166:125\u201333.","journal-title":"Drug Alcohol Depend"},{"key":"1153_CR45","doi-asserted-by":"crossref","unstructured":"Zamboni L, Portoghese I, Congiu A, Zandonai T, Casari R, Fusina F, et al. Polysubstance use patterns among high dose benzodiazepine users: a latent class analysis and differences between male and female use. Front Psychiatr. 2022;13.","DOI":"10.3389\/fpsyt.2022.811130"},{"issue":"10","key":"1153_CR46","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","volume":"38","author":"M Vogel","year":"2013","unstructured":"Vogel M, Kn\u00f6pfli B, Schmid O, Prica M, Strasser J, Prieto L, et al. Treatment or \u201chigh\u201d: benzodiazepine use in patients on injectable heroin or oral opioids. Addict Behav. 2013;38(10):2477\u201384.","journal-title":"Addict Behav"},{"issue":"4","key":"1153_CR47","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/clpt.1984.215","volume":"36","author":"KL Preston","year":"1984","unstructured":"Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA. Diazepam and methadone interactions in methadone maintenance. Clin Pharmacol Ther. 1984;36(4):534\u201341.","journal-title":"Clin Pharmacol Ther"},{"issue":"67","key":"1153_CR48","first-page":"1","volume":"28","author":"E Hughes","year":"2024","unstructured":"Hughes E, Harris J, Ainscough T, Bate A, Copello A, Dalkin S, et al. Care models for coexisting serious mental health and alcohol\/drug conditions: the RECO realist evidence synthesis and case study evaluation. Health Technol Assess (Winchester, England). 2024;28(67):1.","journal-title":"Health Technol Assess (Winchester, England)"},{"issue":"5","key":"1153_CR49","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/S2352-3018(19)30036-0","volume":"6","author":"A McAuley","year":"2019","unstructured":"McAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. The Lancet HIV. 2019;6(5):e315\u201324.","journal-title":"The Lancet HIV"},{"issue":"4","key":"1153_CR50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jsat.2009.03.006","volume":"37","author":"M Fats\u00e9as","year":"2009","unstructured":"Fats\u00e9as M, Lavie E, Denis C, Auriacombe M. Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients. J Subst Abuse Treat. 2009;37(4):407\u201311.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"1153_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","volume":"99","author":"E Lavie","year":"2009","unstructured":"Lavie E, Fats\u00e9as M, Denis C, Auriacombe M. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence. Drug Alcohol Depend. 2009;99(1):338\u201344.","journal-title":"Drug Alcohol Depend"},{"key":"1153_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.addbeh.2016.08.020","volume":"65","author":"RK McHugh","year":"2017","unstructured":"McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addict Behav. 2017;65:283\u20138.","journal-title":"Addict Behav"},{"key":"1153_CR53","volume-title":"Developments in the management of benzodiazepine dependence: the views of Scottish addiction prescribers","author":"J Schofield","year":"2021","unstructured":"Schofield J, Matheson C, Anderson S, Turner M, Bloomfield H. Developments in the management of benzodiazepine dependence: the views of Scottish addiction prescribers. Stirling: University of Stirling; 2021."},{"key":"1153_CR54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugpo.2019.07.038","volume":"74","author":"JS Chang","year":"2019","unstructured":"Chang JS, Behar E, Coffin PO. Narratives of people who inject drugs on factors contributing to opioid overdose. International Journal of Drug Policy. 2019;74:26\u201332.","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"1153_CR55","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12913-023-10201-7","volume":"23","author":"K Berry","year":"2023","unstructured":"Berry K, Matheson C, Schofield J, Dumbrell J, Parkes T, Hill D, et al. Development of an intervention to manage benzodiazepine dependence and high-risk use in the context of escalating drug related deaths in Scotland: an application of the MRC framework. BMC Health Serv Res. 2023;23(1):1205.","journal-title":"BMC Health Serv Res"},{"key":"1153_CR56","doi-asserted-by":"crossref","unstructured":"Park TW, Sikov J, dellaBitta V, Saitz R, Walley AY, Drainoni ML. \u201cIt could potentially be dangerous... but nothing else has seemed to help me.\u201d: patient and clinician perspectives on benzodiazepine use in opioid agonist treatment. J Subst Abuse Treat. 2021;131:108455.","DOI":"10.1016\/j.jsat.2021.108455"},{"issue":"3","key":"1153_CR57","doi-asserted-by":"publisher","first-page":"e074668","DOI":"10.1136\/bmjopen-2023-074668","volume":"14","author":"CS Best","year":"2024","unstructured":"Best CS, Matheson C, Robertson J, Ritchie T, Cowden F, Dumbrell J, et al. Association between benzodiazepine coprescription and mortality in people on opioid replacement therapy: a population-based cohort study. BMJ Open. 2024;14(3):e074668.","journal-title":"BMJ Open"},{"issue":"5","key":"1153_CR58","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1360-0443.2005.01051.x","volume":"100","author":"P Dietze","year":"2005","unstructured":"Dietze P, Jolley D, Fry C, Bammer G. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction. 2005;100(5):636\u201342.","journal-title":"Addiction"},{"key":"1153_CR59","doi-asserted-by":"publisher","first-page":"109707","DOI":"10.1016\/j.drugalcdep.2022.109707","volume":"241","author":"KL Morford","year":"2022","unstructured":"Morford KL, Tetrault JM, Zhou B, Li F, Gleeson B, Edelman EJ, et al. The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: a retrospective cohort study. Drug Alcohol Depend. 2022;241:109707.","journal-title":"Drug Alcohol Depend"},{"key":"1153_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","volume":"200","author":"VR Votaw","year":"2019","unstructured":"Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend. 2019;200:95\u2013114.","journal-title":"Drug Alcohol Depend"},{"issue":"02","key":"1153_CR61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1055\/s-2007-1014658","volume":"21","author":"D Ladewig","year":"1988","unstructured":"Ladewig D, Grossenbacher H. Benzodiazepine abuse in patients of doctors in domiciliary practice in the Basle area. Pharmacopsychiatry. 1988;21(02):104\u20138.","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"1153_CR62","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.drugalcdep.2011.05.004","volume":"118","author":"SE McCabe","year":"2011","unstructured":"McCabe SE, West BT, Teter CJ, Ross-Durow P, Young A, Boyd CJ. Characteristics associated with the diversion of controlled medications among adolescents. Drug Alcohol Depend. 2011;118(2):452\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1153_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1592\/phco.31.3.262","volume":"31","author":"ME McLarnon","year":"2011","unstructured":"McLarnon ME, Monaghan TL, Stewart SH, Barrett SP. Drug misuse and diversion in adults prescribed anxiolytics and sedatives. Pharmacother J Human Pharmacol Drug Ther. 2011;31(3):262\u201372. https:\/\/doi.org\/10.1592\/phco.31.3.262.","journal-title":"Pharmacother J Human Pharmacol Drug Ther"},{"issue":"1","key":"1153_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/02791072.2013.764232","volume":"45","author":"GE Iba\u00f1ez","year":"2013","unstructured":"Iba\u00f1ez GE, Levi-Minzi MA, Rigg KK, Mooss AD. Diversion of benzodiazepines through healthcare sources. J Psychoact Drugs. 2013;45(1):48\u201356.","journal-title":"J Psychoact Drugs"},{"key":"1153_CR65","unstructured":"Ford C, Law F. Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice. 2014."},{"issue":"8","key":"1153_CR66","first-page":"5","volume":"13","author":"Medicines Healthcare products Regulatory Agency","year":"2020","unstructured":"Medicines Healthcare products Regulatory Agency. Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression. Drug Saf Updat. 2020;13(8):5.","journal-title":"Drug Saf Updat"},{"key":"1153_CR67","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2296-14-191","volume":"14","author":"C Sirdifield","year":"2013","unstructured":"Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN. General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract. 2013;14:191.","journal-title":"BMC Fam Pract"},{"issue":"5","key":"1153_CR68","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0005-7967(96)00119-2","volume":"35","author":"NE Turner","year":"1997","unstructured":"Turner NE, Annis HM, Sklar SM. Measurement of antecedents to drug and alcohol use: psychometric properties of the inventory of drug-taking situations (IDTS). Behav Res Ther. 1997;35(5):465\u201383.","journal-title":"Behav Res Ther"},{"issue":"11","key":"1153_CR69","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1360-0443.2010.02933.x","volume":"105","author":"M Liebrenz","year":"2010","unstructured":"Liebrenz M, Boesch L, Stohler R, Caflisch C. Agonist substitution\u2013a treatment alternative for high-dose benzodiazepine-dependent patients? Addiction. 2010;105(11):1870\u20134.","journal-title":"Addiction"},{"key":"1153_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.drugpo.2017.07.012","volume":"49","author":"R Motta-Ochoa","year":"2017","unstructured":"Motta-Ochoa R, Bertrand K, Arruda N, Jutras-Aswad D, Roy \u00c9. \u201cI love having benzos after my coke shot\u201d: The use of psychotropic medication among cocaine users in downtown Montreal. Int J Drug Policy. 2017;49:15\u201323.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1153_CR71","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11524-006-9054-5","volume":"83","author":"M Neira-Le\u00f3n","year":"2006","unstructured":"Neira-Le\u00f3n M, Barrio G, Brugal MT, de la Fuente L, Ballesta R, Bravo MJ, et al. Do young heroin users in madrid, barcelona and seville have sufficient knowledge of the risk factors for unintentional opioid overdose? J Urban Health. 2006;83(3):477\u201396.","journal-title":"J Urban Health"},{"key":"1153_CR72","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.drugalcdep.2015.12.018","volume":"159","author":"C Rowe","year":"2016","unstructured":"Rowe C, Santos G-M, Behar E, Coffin PO. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016;159:234\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"1153_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jsat.2017.03.002","volume":"77","author":"MD Stein","year":"2017","unstructured":"Stein MD, Anderson BJ, Kenney SR, Bailey GL. Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder. J Subst Abuse Treat. 2017;77:67\u201371.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"1153_CR74","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/09595239996383","volume":"18","author":"J Strang","year":"1999","unstructured":"Strang J, Griffiths P, Powis B, Fountain J, Williamson S, Gossop M. Which drugs cause overdose among opiate misusers? Study of personal and witnessed overdoses. Drug Alcohol Rev. 1999;18(3):253\u201361.","journal-title":"Drug Alcohol Rev"},{"key":"1153_CR75","volume-title":"Evaluating a pilot intervention development programme utilising respiratory monitoring to prevent drug-related deaths","author":"K Hn\u00edzdilov\u00e1","year":"2024","unstructured":"Hn\u00edzdilov\u00e1 K, Stephens BP, Ahmad F, Sharkey C, Qumsieh J, Henderson B, et al. Evaluating a pilot intervention development programme utilising respiratory monitoring to prevent drug-related deaths. Lisbon: Lisbon Addictions; 2024."},{"issue":"1","key":"1153_CR76","doi-asserted-by":"publisher","first-page":"22663","DOI":"10.1038\/s41598-021-01990-0","volume":"11","author":"J Chan","year":"2021","unstructured":"Chan J, Iyer V, Wang A, Lyness A, Kooner P, Sunshine J, et al. Closed-loop wearable naloxone injector system. Sci Rep. 2021;11(1):22663.","journal-title":"Sci Rep"},{"issue":"7","key":"1153_CR77","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/S2468-2667(23)00082-8","volume":"8","author":"A McAuley","year":"2023","unstructured":"McAuley A, Fraser R, Glancy M, Yeung A, Jones HE, Vickerman P, et al. Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011\u201320: a national retrospective cohort study. Lancet Public Health. 2023;8(7):e484\u201393.","journal-title":"Lancet Public Health"},{"issue":"3","key":"1153_CR78","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/bcp.14231","volume":"86","author":"F Measham","year":"2020","unstructured":"Measham F. City checking: Piloting the UK\u2019s first community-based drug safety testing (drug checking) service in 2 city centres. Br J Clin Pharmacol. 2020;86(3):420\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"1153_CR79","unstructured":"Bronfenbrenner U. Ecology of the family as a context for human development: Research perspectives. Adolescents and their families. 2013; 1\u201320."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01153-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:45:19Z","timestamp":1740728719000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01153-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01153-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.26.24311053","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Faculty of Health Sciences Committee for Research Ethics, University of Bristol (ref 11906).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All interview participants provided written informed consent to participate in the study, and consent for anonymised quotes from their interviews to be included in published work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests were declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}],"article-number":"24"}}